Former Karuna crew quickly assembles $225M for next neuro bet at Seaport
The team at Seaport Therapeutics, a Boston neuropsychiatry biotech, is having a good fall season. Seaport said Monday it has pieced together $225 million from
The team at Seaport Therapeutics, a Boston neuropsychiatry biotech, is having a good fall season. Seaport said Monday it has pieced together $225 million from
Hearing loss was linked with higher Parkinson’s disease risk. Severity of hearing loss was tied to incident Parkinson’s in a dose-dependent way. Early interventions with
A shorter regimen of three cycles of adjuvant chemotherapy was noninferior to a standard six-cycle regimen among patients with pathologically high-risk retinoblastoma, a Chinese randomized
When given the option, patients ages 45-49 completed colorectal cancer (CRC) screening via fecal immunochemical test (FIT) at about the same rate as 50-year-olds, according
CHICAGO — An investigational dual-action inhibitor for geographic atrophy (GA) significantly slowed disease progression and improved visual acuity after 3 months of treatment, a small
Most adolescents who started gender-affirming medical care didn’t regret it, according to survey responses from participants in the Trans Youth Project. Out of 220 youths,
A novel at-home molecular test proved highly accurate for diagnosing three common sexually transmitted infections (STIs) in females, according to a clinical study from the
Workers at seven CVS pharmacies in Southern California have gone on strike for better pay and healthcare and to protest what they say is bad-faith
Nationwide, infant mortality was higher than expected in the months that followed the Supreme Court decision Dobbs v. Jackson Women’s Health Organization that eliminated federal
Andrews is a pediatrician. I often tell medical students and residents that you can determine much of what you need to know about a patient